JP2003533479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003533479A5 JP2003533479A5 JP2001583765A JP2001583765A JP2003533479A5 JP 2003533479 A5 JP2003533479 A5 JP 2003533479A5 JP 2001583765 A JP2001583765 A JP 2001583765A JP 2001583765 A JP2001583765 A JP 2001583765A JP 2003533479 A5 JP2003533479 A5 JP 2003533479A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disease
- condition
- alkyl
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 description 16
- 125000000217 alkyl group Chemical group 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241000124008 Mammalia Species 0.000 description 4
- -1 1,1-dimethylheptyl Chemical group 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 201000005112 urinary bladder cancer Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20493500P | 2000-05-17 | 2000-05-17 | |
| US60/204,935 | 2000-05-17 | ||
| PCT/US2001/016150 WO2001087297A1 (en) | 2000-05-17 | 2001-05-17 | Cannabinoid drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003533479A JP2003533479A (ja) | 2003-11-11 |
| JP2003533479A5 true JP2003533479A5 (enExample) | 2008-07-10 |
Family
ID=22760084
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583763A Pending JP2003533478A (ja) | 2000-05-17 | 2001-05-17 | （３ｒ，４ｒ）−δ８−テトラヒドロカンナビノール−１１−酸に基づく細胞増殖の低減方法 |
| JP2001583765A Pending JP2003533479A (ja) | 2000-05-17 | 2001-05-17 | カンナビノイド薬剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583763A Pending JP2003533478A (ja) | 2000-05-17 | 2001-05-17 | （３ｒ，４ｒ）−δ８−テトラヒドロカンナビノール−１１−酸に基づく細胞増殖の低減方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6448288B1 (enExample) |
| EP (2) | EP1307188B1 (enExample) |
| JP (2) | JP2003533478A (enExample) |
| CN (2) | CN1227007C (enExample) |
| AT (1) | ATE406156T1 (enExample) |
| AU (5) | AU2001264680B2 (enExample) |
| CA (2) | CA2409005A1 (enExample) |
| DE (1) | DE60135557D1 (enExample) |
| HU (2) | HUP0700039A2 (enExample) |
| IL (3) | IL152891A0 (enExample) |
| NZ (2) | NZ523028A (enExample) |
| RU (2) | RU2272620C2 (enExample) |
| WO (3) | WO2001087296A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005533748A (ja) | 2002-03-08 | 2005-11-10 | シグナル ファーマシューティカルズ，インコーポレイテッド | 増殖性障害および癌を治療、予防、または管理するための併用療法 |
| ATE394124T1 (de) * | 2002-06-06 | 2008-05-15 | Yissum Res Dev Co | Verfahren, zusammensetzungen und herstellungsgegenstände zur modulierung des knochenwachstums |
| WO2004058251A1 (en) * | 2002-12-19 | 2004-07-15 | University Of Massachusetts | Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators |
| WO2004113320A1 (en) * | 2003-05-20 | 2004-12-29 | The University Of Tennessee Research Foundation | Cannabinoid derivatives, methods of making, and use thereof |
| US20050070718A1 (en) | 2003-09-30 | 2005-03-31 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| GB2418612A (en) * | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| US20060128738A1 (en) * | 2004-12-13 | 2006-06-15 | Indevus Pharmaceuticals, Inc. | Treatment of interstitial cystitis using cannabinoid analogs |
| US20060128794A1 (en) | 2004-12-13 | 2006-06-15 | Indevus Pharmaceuticals, Inc. | Treatment of interstitial cystitis using (6aR,10aR)-delta8-tetrahydrocannabinol-11-OIC acids |
| US20070037873A1 (en) * | 2005-08-08 | 2007-02-15 | Zurier Robert B | Airway remodeling treatments |
| US7597910B2 (en) * | 2005-08-20 | 2009-10-06 | Slgm Medical Research Institute | Compositions and methods for treating prostate disorders |
| EP1928853A4 (en) * | 2005-09-29 | 2011-02-16 | Amr Technology Inc | PROCESS FOR THE PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL |
| WO2007047010A2 (en) * | 2005-10-20 | 2007-04-26 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of cannabinoid analogs |
| US20070099988A1 (en) * | 2005-10-31 | 2007-05-03 | Indevus Pharmaceuticals, Inc. | Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids |
| US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
| US20080167286A1 (en) | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
| UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
| US7781650B2 (en) * | 2007-04-30 | 2010-08-24 | Monsanto Technology Llc | Plants and seeds of corn variety CV202909 |
| WO2008144475A1 (en) | 2007-05-17 | 2008-11-27 | California Pacific Medical Center | Methods and compositions for treating cancer |
| CN101952276B (zh) | 2007-12-07 | 2014-10-22 | Abbvie德国有限责任两合公司 | 5-卤素取代的羟吲哚衍生物和其用于治疗加压素依赖性疾病的用途 |
| MX2010006202A (es) | 2007-12-07 | 2011-03-04 | Abbott Gmbh & Co Kg | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. |
| CA2707671C (en) | 2007-12-07 | 2016-02-02 | Abbott Gmbh & Co. Kg | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| WO2010009775A1 (de) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| US9040568B2 (en) | 2009-05-29 | 2015-05-26 | Abbvie Inc. | Pharmaceutical compositions for the treatment of pain |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| JP2020529421A (ja) | 2017-08-04 | 2020-10-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | がんの処置のためのＰＤ−１アンタゴニストおよびベンゾ［ｂ］チオフェンＳＴＩＮＧアゴニストの組み合わせ |
| CA3071538A1 (en) | 2017-08-04 | 2019-02-07 | Merck Sharp & Dohme Corp. | Benzo[b]thiophene sting agonists for cancer treatment |
| CN111233814A (zh) * | 2020-03-02 | 2020-06-05 | 福建省中科生物股份有限公司 | 一种萜酚类化合物zkyy-057及其制备方法和应用 |
| US12029718B2 (en) | 2021-11-09 | 2024-07-09 | Cct Sciences, Llc | Process for production of essentially pure delta-9-tetrahydrocannabinol |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| US4327028A (en) * | 1978-08-17 | 1982-04-27 | Calcol, Inc. | Composition of matter |
| ZA885929B (en) * | 1987-08-25 | 1989-04-26 | Oxi Gene Inc | Agents for use in tumor or cancer cell killing therapy |
| US4973603A (en) * | 1988-06-16 | 1990-11-27 | Sumner Burstein | Platelet activating factor antagonist and methods of use therefor |
| US4880030A (en) * | 1988-07-25 | 1989-11-14 | Terry Paul E | Safety flow control fluid shutoff device |
| US5635530A (en) * | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
| US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
| US5338753A (en) | 1992-07-14 | 1994-08-16 | Sumner H. Burstein | (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics |
| US6162829A (en) * | 1997-10-17 | 2000-12-19 | Atlantic Pharmaceuticals, Inc. | (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| ES1045342Y (es) * | 2000-02-11 | 2001-02-16 | Alvarez Manuel Couto | Expositor giratorio para postales, fotos y similares. |
-
2001
- 2001-05-08 US US09/851,122 patent/US6448288B1/en not_active Expired - Lifetime
- 2001-05-17 CN CNB018129161A patent/CN1227007C/zh not_active Expired - Fee Related
- 2001-05-17 HU HU0700039A patent/HUP0700039A2/hu unknown
- 2001-05-17 JP JP2001583763A patent/JP2003533478A/ja active Pending
- 2001-05-17 CN CNB018130100A patent/CN1273123C/zh not_active Expired - Fee Related
- 2001-05-17 WO PCT/US2001/015927 patent/WO2001087296A1/en not_active Ceased
- 2001-05-17 NZ NZ523028A patent/NZ523028A/en unknown
- 2001-05-17 DE DE60135557T patent/DE60135557D1/de not_active Expired - Fee Related
- 2001-05-17 CA CA002409005A patent/CA2409005A1/en not_active Abandoned
- 2001-05-17 AU AU2001264680A patent/AU2001264680B2/en not_active Ceased
- 2001-05-17 IL IL15289101A patent/IL152891A0/xx unknown
- 2001-05-17 AU AU2001261695A patent/AU2001261695B2/en not_active Ceased
- 2001-05-17 AU AU6169501A patent/AU6169501A/xx active Pending
- 2001-05-17 IL IL15289201A patent/IL152892A0/xx unknown
- 2001-05-17 RU RU2002133869/14A patent/RU2272620C2/ru not_active IP Right Cessation
- 2001-05-17 AU AU6468001A patent/AU6468001A/xx active Pending
- 2001-05-17 CA CA002408961A patent/CA2408961A1/en not_active Abandoned
- 2001-05-17 WO PCT/US2001/015916 patent/WO2001087295A1/en not_active Ceased
- 2001-05-17 AT AT01939128T patent/ATE406156T1/de not_active IP Right Cessation
- 2001-05-17 NZ NZ523029A patent/NZ523029A/en unknown
- 2001-05-17 JP JP2001583765A patent/JP2003533479A/ja active Pending
- 2001-05-17 WO PCT/US2001/016150 patent/WO2001087297A1/en not_active Ceased
- 2001-05-17 EP EP01939128A patent/EP1307188B1/en not_active Expired - Lifetime
- 2001-05-17 RU RU2002133868/15A patent/RU2273476C2/ru not_active IP Right Cessation
- 2001-05-17 AU AU2001263217A patent/AU2001263217A1/en not_active Abandoned
- 2001-05-17 HU HU0700038A patent/HUP0700038A2/hu unknown
- 2001-05-17 US US10/276,819 patent/US6914072B2/en not_active Expired - Fee Related
- 2001-05-17 EP EP01935616A patent/EP1307186A4/en not_active Withdrawn
-
2002
- 2002-11-17 IL IL152892A patent/IL152892A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003533479A5 (enExample) | ||
| RU2002133868A (ru) | Каннабиноидные лекарственные средства | |
| JPH0564930B2 (enExample) | ||
| JP2003509349A5 (enExample) | ||
| JP2003500450A5 (enExample) | ||
| JPWO1992021345A1 (ja) | 抗腫瘍効果増強のための及び腫瘍治療のための組成物 | |
| JP2003519228A5 (enExample) | ||
| JP2002535370A5 (enExample) | ||
| Gershanovich et al. | Results of clinical study of antitumor action of hydrazine sulfate | |
| JP2003519181A5 (enExample) | ||
| KR20040030788A (ko) | 요실금 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체 | |
| JP2002544227A5 (enExample) | ||
| JP2002510690A5 (enExample) | ||
| JP3384539B2 (ja) | 喘息治療剤 | |
| JP2019516727A5 (enExample) | ||
| JP2007045781A (ja) | Ｔｓ−１／カンプトテシン類による化学放射線療法 | |
| RU2006101061A (ru) | Азенапин для лечения шизофрении у пациентов с избыточной массой тела или предрасположенностью к избыточной массе тела | |
| WO1992004028A1 (en) | Antineoplastic effect potentiator and antineoplastic agent | |
| JP2002522462A5 (enExample) | ||
| AU731260B2 (en) | Therapeutic treatment for sexual dysfunctions | |
| JP2003534318A5 (enExample) | ||
| EP0623346B1 (en) | Inhibitor for metastasis of malignant tumor | |
| MORFIT | Lymphangioma of the Tongue: Treatment and Appraisal of Long-Term Results | |
| US20230167120A1 (en) | Aryl-fused isoselenazole compound containing tetrazine substituent, synthesis method therefor, and use thereof | |
| JP2008515947A5 (enExample) |